Affinity-matured CD72-targeting nanobody CAR T cells enhance elimination of antigen-low B-cell malignancies is a research paper published in Journal for ImmunoTherapy of Cancer (2025). On theSindex it has a DataRank of 0.104. It has been cited 1 time.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.104
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Intramural Research Program, Center of Cancer Research, National Cancer Institute and NIH Clinical Center
Grant: N/A
UCSF Medical Scientist Training Program
Grant: T32GM141323
Contrato Río Hortega by the Instituto de Salud Carlos III
Grant: CM24/00094
TERAV+ by RICORS/TERAV
Grant: RD24/0014/0003
Dept. of Defense Congressionally Directed Medical Research Program Award
Grant: W81XWH2210807
UCSF Helen Diller Family Comprehensive Cancer Center Preclinical Therapeutic Core Facility
Grant: P30CA082103
National Institute of Health
Grant: ZIA BC 011823
NIH
Grant: T32AI007529
National Institutes of Health
Grant: 5T32AI007529-09
TRAINING IN TRANSPLANTATION BIOLOGY
National Institutes of Health
Grant: 5T32GM141323-03
Medical Scientist Training Program (T32 NRSA Training Grant)
National Institutes of Health
Grant: 3P30CA082103-21S2
Cancer Center Support Grant
Fields of Study
MeSH Terms
Keywords